Bioprocess containers market to grow to $9.6 billion by 2026

The bioprocess container market is projected to grow from USD $2.9 billion in 2021 to USD $9.6 billion by 2026, at a CAGR of 26.3% during the forecast period, according to a recent market research report from MarketsandMarkets. 

The report, entitled Bioprocess Containers Market by Type(2D and 3D Bags, Accessories), Application(Process development, Upstream and Downstream Process), End User(Pharma & Biopharma Companies, CMOs & CROs, Academic & Research Institute), & Region – Global Forecast to 2026, attributes the projected growth to factors including:

• A buoyant biologics market
• The affordability and sustainability of single-use bioprocess technologies
• Rising biopharmaceutical research and development

Commenting on the report, ALLpaQ Managing Director Phill Allen said the findings chimed with those experienced by his own company over the past two years. “The liquid handling market has indeed seen increasing demand from pharmaceutical, life science and biotechnology companies for sustainable secondary packaging solutions,” remarked Mr Allen. 

MarketsandMarkets’ research follows hot on the heels of another report, from Axiom Market Research & Consulting, which named ALLpaQ as a ‘key player’ in the growth of the bioprocess containment market. 

The research report also found a thriving bioprocess containment market buoyed by increasing demand for low-cost biologic drugs and considerations around the sustainability of single-use technologies.

MarketsandMarkets bioprocess containment report overview

The revealing research report from MarketsandMarkets looks at attributable growth factors on the bioprocess container market. Key points from the report, include: 

• The 2D bioprocess containers segment accounted for the largest share of the type segment in the BPCs market in 2020.
• The pharmaceutical & biopharmaceutical companies segment accounted for the largest share of the end-user segment in the market in 2020.  
• The Asia Pacific region is the fastest-growing region of the bioprocess containers market in 2020.  

You can view the full MarketsandMarkets’ report here. 

MarketsandMarkets’ research report also provides insights as regards the impact of the COVID-19 pandemic. COVID-19, the infectious disease caused by the most recently discovered novel coronavirus, has been declared a global pandemic by the World Health Organization (WHO). Since the outbreak began in December 2019, pharmaceutical companies, along with players in the bioprocess containers market, have led the way in the development of treatments and vaccines. 

MarketsandMarkets’s research finds that, since the majority of the prevailing COVID-19 vaccine programmes harness novel approaches, including mRNA, DNA vaccine, and vectors, these platforms are largely built on single-use technology. 

As such, most of the pandemic-related new facilities are choosing to embrace single-use systems. This, according to the report, is “due to their flexibility combined with high speed and much lower capital investment when compared to traditional stainless steel equipment”.  

The surge in single-use technologies for COVID-19 pandemic-related research along with increasing vaccine development is therefore projected to have a positive impact on the bioprocess containers market.

You can view the full MarketsandMarkets’ report here.

PRESS NOTES TO EDITORS

More about MarketsandMarkets

MarketsandMarkets provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. 

Hit the link to discover more about MarketsandMarkets and its bioprocess container market report.

Author

ALLpaQ

Packaging

ALLpaQ is the market leader in the design of innovative pharma containers and fluid management solutions.

Follow me